Stoichiometry and affinity of the human serum albumin-Alzheimer's Aβ peptide interactions

Biophysical Journal

Volumn 100, Issue 1, 2011, Pages 183-192

  Milojevic, Julijana ^a   Melacini, Giuseppe ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651245383     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.11.037     Document Type: Article

References (30)

1. Deane, R., Z. H. Wu, and B. V. Zlokovic. 2004. RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid b-peptide clearance through transport across the blood-brain barrier. Stroke. 35 (Suppl 1): 2628-2631.
2. Llewellyn, D. J., K. M. Langa, ., I. A. Lang. 2010. Serum albumin concentration and cognitive impairment. Curr. Alzheimer Res. 7:91-96.
3. Boada, M., P. Ortiz, ., A. Páez. 2009. Amyloid-targeted therapeutics in Alzheimer's disease: Use of human albumin in plasma exchange as a novel approach for Ab mobilization. Drug News Perspect. 22:325-339.
4. Milojevic, J., A. Raditsis, and G. Melacini. 2009. Human serum albumin inhibits Ab fibrilization through a "monomer-competitor" mechanism. Biophys. J. 97:2585-2594.
5. Milojevic, J., V. Esposito, ., G. Melacini. 2007. Understanding the molecular basis for the inhibition of the Alzheimer's Ab-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. J. Am. Chem. Soc. 129:4282-4290.
6. Biere, A. L., B. L. Ostaszewski, ., D. J. Selkoe. 1996. Amyloid b-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271:32916-32922.
7. Bohrmann, B., L. Tjernberg, ., C. Nordstedt. 1999. Endogenous proteins controlling amyloid b-peptide polymerization. Possible implications for b-amyloid formation in the central nervous system and in peripheral tissues. J. Biol. Chem. 274:15990-15995.
8. Rózga, M., M. K1oniecki, ., W. Bal. 2007. The binding constant for amyloid Ab40 peptide interaction with human serum albumin. Biochem. Biophys. Res. Commun. 364:714-718.
9. Reyes Barcelo, A. A., F. J. Gonzalez-Velasquez, and M. A. Moss. 2009. Soluble aggregates of the amyloid-b peptide are trapped by serum albumin to enhance amyloid-b activation of endothelial cells. J. Biol. Eng. 3:5.
10. Varshney, A., P. Sen, ., R. H. Khan. 2010. Ligand binding strategies of human serum albumin: how can the cargo be utilized? Chirality. 22:77-87.
11. Bhattacharya, A. A., T. Grüne, and S. Curry. 2000. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303:721-732.
12. Yan, Y. L., Y. Z. Liu,., C. Y.Wang. 2007. Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Ab interaction. Biochemistry (NY). 46:1724-1731.
13. Mayer, M., and B. Meyer. 2001. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123:6108-6117.
14. Huang, H., J. Milojevic, and G. Melacini. 2008. Analysis and optimization of saturation transfer difference NMR experiments designed to map early self-association events in amyloidogenic peptides. J. Phys. Chem. B. 112:5795-5802.
15. Esposito, V., R. Das, and G. Melacini. 2005. Mapping polypeptide selfrecognition through 1H off-resonance relaxation. J. Am. Chem. Soc. 127:9358-9359.
16. Milojevic, J., V. Esposito, ., G. Melacini. 2006. Analysis and parametric optimization of 1H off-resonance relaxation NMR experiments designed to map polypeptide self-recognition and other noncovalent interactions. J. Phys. Chem. B. 110:20664-20670.
17. Mansfield, S. L., D. A. Jayawickrama,., C. K. Larive. 1998. Measurement of peptide aggregation with pulsed-field gradient nuclear magnetic resonance spectroscopy. Biochim. Biophys. Acta. 1382:257-265.
18. Zhang, S. S., N. Casey, and J. P. Lee. 1998. Residual structure in the Alzheimer's disease peptide: Probing the origin of a central hydrophobic cluster. Fold. Des. 3:413-422.
19. Jarvet, J., P. Damberg, ., A. Graslund. 2000. Reversible random coil to b-sheet transition and the early stage of aggregation of the Ab (12-28) fragment from the Alzheimer peptide. J. Am. Chem. Soc. 122:4261-4268.
20. Mao, H. Y., A. H. Gunasekera, and S. W. Fesik. 2000. Expression, refolding, and isotopic labeling of human serum albumin domains for NMR spectroscopy. Protein Expr. Purif. 20:492-499.
21. Hou, L. M., H. Y. Shao, ., M. G. Zagorski. 2004. Solution NMR studies of the Ab (1-40) and Ab (1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J. Am. Chem. Soc. 126:1992-2005.
22. Ahmed, M., J. Davis, ., S. O. Smith. 2010. Structural conversion of neurotoxic amyloid-b (1-42) oligomers to fibrils. Nat. Struct. Mol. Biol. 17:561-567.
23. Bitan, G., M. D. Kirkitadze,., D. B. Teplow. 2003. Amyloid b-protein (Ab) assembly: Ab 40 and Ab 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA. 100:330-335.
24. Kooistra, J., J. Milojevic,., J. Ortega. 2009. A new function of human HtrA2 as an amyloid-b oligomerization inhibitor. J. Alzheimers Dis. 17:281-294.
25. Sgourakis, N. G., Y. L. Yan, ., A. E. Garcia. 2007. The Alzheimer's peptides Ab40 and 42 adopt distinct conformations in water: A combined MD/NMR study. J. Mol. Biol. 368:1448-1457.
26. Triguero, L., R. Singh, and R. Prabhakar. 2008. Comparative molecular dynamics studies of wild-type and oxidized forms of full-length Alzheimer amyloid beta-peptides Ab (1-40) and Ab (1-42). J. Phys. Chem. B. 112:7123-7131.
27. Lührs, T., C. Ritter, ., R. Riek. 2005. 3D structure of Alzheimer's amyloid-b (1-42) fibrils. Proc. Natl. Acad. Sci. USA. 102:17342-17347.
28. Cavani, S., A. Tamaoka, ., H. Mori. 2000. Plasma levels of amyloid b 40 and b42 are independent from ApoE genotype and mental retardation in Down syndrome. Am. J. Med. Genet. 95:224-228.
29. Hindo, S. S., A. M. Mancino, ., M. H. Lim. 2009. Small molecule modulators of copper-induced Ab aggregation. J. Am. Chem. Soc. 131:16663-16665.
30. Nanga, R. P. R., J. R. Brender, ., A. Ramamoorthy. 2009. Threedimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. J. Am. Chem. Soc. 131:8252-8261.